Smithers enters peptide testing by buying ACS Laboratory
A testing group founded in 1925 has bought the Florida lab now trading as ACS Peptide Testing Labs. The release is worth reading for what it does not name.
All stories
Bacterial endotoxin testing, assessed as documentation a purity figure cannot supply
A percentage by HPLC is a chemical result. Endotoxin is a microbiological one, with its own method, its own calculated limit and its own report. Assessed on what a bacterial endotoxins test records and what it leaves open.
A 70-month sentence puts forged laboratory certificates on the record
The operator of a research-chemical seller was sentenced in late July after admitting the business forged laboratory certificates. For a market that runs on seller-hosted PDFs, that admission is the part worth reading.
'Research use only' is a use statement, not a quality grade
The most-printed phrase in research supply carries no method, no measurement and no issuing body. Assessed on what it commits a seller to, how regulators have read it, and which fields on a label do the work instead.
FDA's 503B Bulks List, assessed as a document rather than a verdict
A public, dated, numbered federal docket that circulates as though it were a register of approved substances. Assessed on what the notices record, how the process moves, and how little of it bears on a research-supply purchase.
The word 'peptide' is now doing two jobs on a label
Three August supplement launches print 'peptide' on the front of the container. The paperwork behind that word is a different kind of document from the one a research-supply buyer reads.
Lot traceability and vial labelling, assessed across the category
The label on a lyophilised vial is the only documentation that physically travels with the material. Assessed on what the category prints, what it omits, and what that costs a buyer.
Cold-chain claims outrun cold-chain evidence in peptide shipping
Suppliers increasingly advertise temperature-controlled shipping. Far fewer publish anything that would let a buyer verify the chain held.
The vendor-published certificate of analysis, assessed as evidence
The COA is the central document in research supply and the least examined. Assessed on what it actually establishes, what it leaves open, and how far a buyer can rely on it.
Third-party assay reports become a competition point in research supply
Vendors of research peptides spent years competing on price per milligram. A growing number now compete on whose laboratory signed the report.
